- Home
- MAX vs KURA Comparison
MAX vs KURA Comparison
Compare MAX & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAX
- KURA
- Stock Information
- Founded
- MAX 2014
- KURA 2014
- Country
- MAX United States
- KURA United States
- Employees
- MAX N/A
- KURA N/A
- Industry
- MAX Industrial Machinery/Components
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAX Industrials
- KURA Health Care
- Exchange
- MAX Nasdaq
- KURA Nasdaq
- Market Cap
- MAX 582.4M
- KURA 561.9M
- IPO Year
- MAX 2020
- KURA N/A
- Fundamental
- Price
- MAX $10.35
- KURA $6.44
- Analyst Decision
- MAX Strong Buy
- KURA Strong Buy
- Analyst Count
- MAX 6
- KURA 12
- Target Price
- MAX $17.92
- KURA $24.50
- AVG Volume (30 Days)
- MAX 419.3K
- KURA 1.4M
- Earning Date
- MAX 07-30-2025
- KURA 08-07-2025
- Dividend Yield
- MAX N/A
- KURA N/A
- EPS Growth
- MAX N/A
- KURA N/A
- EPS
- MAX 0.28
- KURA N/A
- Revenue
- MAX $1,002,364,000.00
- KURA $67,991,000.00
- Revenue This Year
- MAX $24.09
- KURA $125.04
- Revenue Next Year
- MAX $11.18
- KURA $83.75
- P/E Ratio
- MAX $37.31
- KURA N/A
- Revenue Growth
- MAX 148.62
- KURA N/A
- 52 Week Low
- MAX $7.33
- KURA $5.41
- 52 Week High
- MAX $20.91
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- MAX 45.90
- KURA 59.02
- Support Level
- MAX $10.05
- KURA $5.65
- Resistance Level
- MAX $11.14
- KURA $6.46
- Average True Range (ATR)
- MAX 0.37
- KURA 0.26
- MACD
- MAX -0.07
- KURA 0.07
- Stochastic Oscillator
- MAX 26.43
- KURA 97.73
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.